Genome-wide association studies in atherothrombosis

European Journal of Internal Medicine

Volumn 21, Issue 2, 2010, Pages 74-78

  Lotta, Luca Andrea ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

Genome wide association study atherothrombotic disease; Genome wide association study coronary artery disease; Genome wide association study myocardial infarction; Genome wide association study stroke

Indexed keywords

DNA;

CEREBROVASCULAR ACCIDENT; DISEASE PREDISPOSITION; DNA DETERMINATION; GENETIC ASSOCIATION; GENETIC LINKAGE; GENETIC VARIABILITY; GENOME; HEART INFARCTION; HEREDITY; HUMAN; MOLECULAR EVOLUTION; SHORT SURVEY; THROMBOSIS;

ATHEROSCLEROSIS; GENES; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; GENOME, HUMAN; GENOME-WIDE ASSOCIATION STUDY; HUMANS; LINKAGE (GENETICS); MYOCARDIAL INFARCTION; RISK FACTORS; STROKE; THROMBOSIS;

EID: 77649182951     PISSN: 09536205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejim.2009.11.003     Document Type: Short Survey

References (55)

1. Lopez A.D., Mathers C.D., Ezzati M., Jamison D.T., and Murray C.J. Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet 367 (2006) 1747-1757
2. Kannel W.B., Dawber T.R., Kagan A., Revotskie N., and Stokes III J. Factors of risk in the development of coronary heart disease-six year follow-up experience. The Framingham Study. Ann Intern Med 55 (1961) 33-50
3. D'Agostino Sr. R.B., Grundy S., Sullivan L.M., and Wilson P. Validation of the Framingham coronary heart disease prediction scores: results of a multiple ethnic groups investigation. JAMA 286 (2001) 180-187
4. Liu J., Hong Y., D'Agostino Sr. R.B., Wu Z., Wang W., Sun J., et al. Predictive value for the Chinese population of the Framingham CHD risk assessment tool compared with the Chinese Multi-Provincial Cohort Study. JAMA 291 (2004) 2591-2599
5. Conroy R.M., Pyörälä K., Fitzgerald A.P., Sans S., Menotti A., De Backer G., et al. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J 24 (2003) 987-1003
6. Wilson P.W., D'Agostino R.B., Levy D., Belanger A.M., Silbershatz H., and Kannel W.B. Prediction of coronary heart disease using risk factor categories. Circulation 97 (1998) 1837-1847
7. Yusuf S., Hawken S., Ounpuu S., Dans T., Avezum A., Lanas F., et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 364 (2004) 937-952
8. Sesso H.D., Lee I.M., Gaziano J.M., Rexrode K.M., Glynn R.J., and Buring J.E. Maternal and paternal history of myocardial infarction and risk of cardiovascular disease in men and women. Circulation 104 (2001) 393-398
9. Friedlander Y., Arbogast P., Schwartz S.M., Marcovina S.M., Austin M.A., Rosendaal F.R., et al. Family history as a risk factor for early onset myocardial infarction in young women. Atherosclerosis 156 (2001) 201-207
10. Rissanen A.M. Familial occurrence of coronary heart disease: effect of age at diagnosis. Am J Cardiol 44 (1979) 60-66
11. Murabito J.M., Pencina M.J., Nam B.H., D'Agostino Sr. R.B., Wang T.J., Lloyd-Jones D., et al. Sibling cardiovascular disease as a risk factor for cardiovascular disease in middle-aged adults. JAMA 294 (2005) 3117-3123
12. Marenberg M.E., Risch N., Berkman L.F., Floderus B., and de Faire U. Genetic susceptibility to death from coronary heart disease in a study of twins. N Engl J Med 330 (1994) 1041-1046
13. Wienke A., Herskind A.M., Christensen K., Skytthe A., and Yashin A.I. The heritability of CHD mortality in Danish twins after controlling for smoking and BMI. Twin Res Hum Genet 8 (2005) 53-59
14. Atherosclerosis, Thrombosis, and Vascular Biology Italian Study Group. No evidence of association between prothrombotic gene polymorphisms and the development of acute myocardial infarction at a young age. Circulation 107 (2003) 1117-1122
15. Dichgans M. Genetics of ischaemic stroke. Lancet Neurol 6 (2007) 149-161
16. International Human Genome Sequencing Consortium. Initial sequencing and analysis of the human genome. Nature 409 (2001) 860-921
17. Redon R., Ishikawa S., Fitch K.R., Feuk L., Perry G.H., Andrews T.D., et al. Global variation in copy number in the human genome. Nature 444 (2006) 444-454
18. International HapMap Consortium. A haplotype map of the human genome. Nature 437 (2005) 1299-1320
19. International HapMap Consortium. A second generation human haplotype map of over 3.1 million SNPs. Nature 449 (2007) 851-861
20. Hardy J., and Singleton A. Genomewide association studies and human disease. N Engl J Med 360 (2009) 1759-1768
21. Hirschhorn J.N., and Daly M.J. Genome-wide association studies for common diseases and complex traits. Nat Rev Genet 6 (2005) 95-108
22. Morgan T.M., Krumholz H.M., Lifton R.P., and Spertus J.A. Non validation of reported genetic risk factors for acute coronary syndrome in a large-scale replication study. JAMA 297 (2007) 1551-1561
23. Strittmatter W.J., Saunders A.M., Schmechel D., Pericak-Vance M., Enghild J., Salvesen G.S., et al. Apolipoprotein E: high-avidity binding to β-amyloid and increased frequency of type 4 allele in late-onset Alzheimer disease. Proc Natl Acad Sci USA 90 (1993) 1977-1981
24. Corder E.H., Saunders A.M., Strittmatter W.J., Schmechel D.E., Gaskell P.C., Small G.W., et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 261 (1993) 921-923
25. Spreafico M., Peyvandi F., Foco L., Bernardinelli L., Duga S., Asselta S., et al. Factor V Leiden, but not prothrombin G20120A, is associated with premature myocardial infarction. Circulation 118 (2008) S_956
26. Jones E.Y., Fugger L., Strominger J.L., and Siebold C. MHC class II proteins and disease: a structural perspective. Nat Rev Immunol 6 (2006) 271-282
27. McCarthy M.I., Abecasis G.R., Cardon L.R., Goldstein D.B., Little J., Ioannidis J.P., et al. Genome-wide association studies for complex traits: consensus, uncertainty and challenges. Nat Rev Genet 9 (2008) 356-369
28. The Wellcome Trust Case Control Consortium. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 447 (2007) 661-678
29. Hindorff, L.A., Junkins, H.A., Mehta, J.P., Manolio, T.A. A Catalog of Published Genome-Wide Association Studies. Available at: www.genome.gov/gwastudies. [accessed 11/14/2009].
30. McPherson R., Pertsemlidis A., Kavaslar N., Stewart A., Roberts R., Cox D.R., et al. A common allele on chromosome 9 associated with coronary heart disease. Science 316 (2007) 1488-1491
31. Helgadottir A., Thorleifsson G., Manolescu A., Gretarsdottir S., Blondal T., Jonasdottir A., et al. A common variant on chromosome 9p21 affects the risk of myocardial infarction. Science 316 (2007) 1491-1493
32. Samani N.J., Erdmann J., Hall A.S., Hengstenberg C., Mangino M., Mayer B., et al. Genomewide association analysis of coronary artery disease. N Engl J Med 357 (2007) 443-453
33. Trégouët D.A., König I.R., Erdmann J., Munteanu A., Braund P.S., Hall A.S., et al. Genome-wide haplotype association study identifies the SLC22A3-LPAL2-LPA gene cluster as a risk locus for coronary artery disease. Nat Genet 41 (2009) 283-285
34. Myocardial Infarction Genetics Consortium. Genome-wide association of early onset myocardial infarction with single nucleotide polymorphisms and copy number variants. Nat Genet 41 (2009) 334-341
35. Erdmann J., Grosshennig A., Braund P.S., König I.R., Hengstenberg C., Hall A.S., et al. New susceptibility locus for coronary artery disease on chromosome 3q22.3. Nat Genet 41 (2009) 280-282
36. Assimes T.L., Knowles J.W., Basu A., Iribarren C., Southwick A., Tang H., et al. Susceptibility locus for clinical and subclinical coronary artery disease at chromosome 9p21 in the multi-ethnic ADVANCE study. Hum Mol Genet 17 (2008) 2320-2328
37. Shen G.Q., Li L., Rao S., Abdullah K.G., Ban J.M., Lee B.S., et al. Four SNPs on chromosome 9p21 in a South Korean population implicate a genetic locus that confers high cross-race risk for development of coronary artery disease. Arterioscler Thromb Vasc Biol 28 (2008) 360-365
38. Hinohara K., Nakajima T., Takahashi M., Hohda S., Sasaoka T., Nakahara K., et al. Replication of the association between a chromosome 9p21 polymorphism and coronary artery disease in Japanese and Korean populations. J Hum Genet 53 (2008) 357-359
39. Zhou L., Zhang X., He M., Cheng L., Chen Y., Hu F.B., et al. Associations between single nucleotide polymorphisms on chromosome 9p21 and risk of coronary heart disease in Chinese Han population. Arterioscler Thromb Vasc Biol 28 (2008) 2085-2089
40. Hiura Y., Fukushima Y., Yuno M., Sawamura H., Kokubo Y., Okamura T., et al. Validation of the association of genetic variants on chromosome 9p21 and 1q41 with myocardial infarction in a Japanese population. Circ J 72 (2008) 1213-1217
41. Maitra A., Dash D., John S., Sannappa P.R., Das A.P., Shanker J., et al. A common variant in chromosome 9p21 associated with coronary artery disease in Asian Indians. J Genet 88 (2009) 113-118
42. Helgadottir A., Thorleifsson G., Magnusson K.P., Grétarsdottir S., Steinthorsdottir V., Manolescu A., et al. The same sequence variant on 9p21 associates with myocardial infarction, abdominal aortic aneurysm and intracranial aneurysm. Nat Genet 40 (2008) 217-224
43. Horne B.D., Carlquist J.F., Muhlestein J.B., Bair T.L., and Anderson J.L. Association of variation in the chromosome 9p21 locus with myocardial infarction versus chronic coronary artery disease. Circ Cardiovasc Genet 1 (2008) 85-92
44. Ye S., Willeit J., Kronenberg F., Xu Q., and Kiechl S. Association of genetic variation on chromosome 9p21 with susceptibility and progression of atherosclerosis: a population-based, prospective study. J Am Coll Cardiol 52 (2008) 378-384
45. Yamagishi K., Folsom A.R., Rosamond W.D., Boerwinkle E., and ARIC investigators. A genetic variant on chromosome 9p21 and incident heart failure in the ARIC study. Eur Heart J 30 (2009) 1222-1228
46. Matarín M., Brown W.M., Scholz S., et al. A genome-wide genotyping study in patients with ischaemic stroke: initial analysis and data release. Lancet Neurol 6 (2007) 414-420
47. Yamada Y., Fuku N., Tanaka M., Aoyagi Y., Sawabe M., Metoki N., et al. Identification of CELSR1 as a susceptibility gene for ischemic stroke in Japanese individuals by a genome-wide association study. Atherosclerosis 207 (2009) 144-149
48. Gretarsdottir S., Thorleifsson G., Manolescu A., Styrkarsdottir U., Helgadottir A., Gschwendtner A., et al. Risk variants for atrial fibrillation on chromosome 4q25 associate with ischemic stroke. Ann Neurol 64 (2008) 402-409
49. Gudbjartsson D.F., Arnar D.O., Helgadottir A., Gretarsdottir S., Holm H., Sigurdsson A., et al. Variants conferring risk of atrial fibrillation on chromosome 4q25. Nature 448 (2007) 353-357
50. Gudbjartsson D.F., Holm H., Gretarsdottir S., Thorleifsson G., Walters G.B., Thorgeirsson G., et al. A sequence variant in ZFHX3 on 16q22 associates with atrial fibrillation and ischemic stroke. Nat Genet 41 (2009) 876-878
51. Ikram M.A., Seshadri S., Bis J.C., Fornage M., DeStefano A.L., Aulchenko Y.S., et al. Genomewide association studies of stroke. N Engl J Med 360 (2009) 1718-1728
52. Kraft P., and Hunter D.J. Genetic risk prediction - are we there yet?. N Engl J Med 360 17 (2009) 1701-1703
53. Hirschhorn J.N. Genomewide association studies - illuminating biologic pathways. N Engl J Med 360 17 (2009) 1699-1701
54. Wang J., Wang W., Li R., Li Y., Tian G., Goodman L., et al. The diploid genome sequence of an Asian individual. Nature 456 (2008) 60-65
55. Wheeler D.A., Srinivasan M., Egholm M., Shen Y., Chen L., McGuire A., et al. The complete genome of an individual by massively parallel DNA sequencing. Nature 452 (2008) 872-876